iGene™ is a revolutionary non-invasive prenatal blood test that can detect fetal chromosomal abnormalities such as Down syndrome, Edward syndrome and Patau syndrome with more than 99.99% accuracy. The test is expected to drastically change the course of prenatal screening because it offers expectant mothers accurate results without the risk of miscarriage. It is anticipated that the use of iGene™ as a prenatal screening tool can reduce the rate at which invasive amniocenteses are performed, by as much as 95%.
iGene™ is a revolutionary non-invasive prenatal blood test that can detect fetal chromosomal abnormalities such as Down syndrome, Edward syndrome and Patau syndrome with more than 99.99% accuracy. The test is expected to drastically change the course of prenatal screening because it offers expectant mothers accurate results without the risk of miscarriage. It is anticipated that the use of iGene™ as a prenatal screening tool can reduce the rate at which invasive amniocenteses are performed, by as much as 95%.
iGene™ is a revolutionary non-invasive prenatal blood test that can detect fetal chromosomal abnormalities such as Down syndrome, Edward syndrome and Patau syndrome with more than 99.99% accuracy. The test is expected to drastically change the course of prenatal screening because it offers expectant mothers accurate results without the risk of miscarriage. It is anticipated that the use of iGene™ as a prenatal screening tool can reduce the rate at which invasive amniocenteses are performed, by as much as 95%.